Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 10:00 AM ET

Date/Time Source News Release
12/13/2024 06:15 PM EST GlobeNewswire Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(TM) (cosibelimab-ipdl)
11/14/2024 04:10 PM EST GlobeNewswire Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/14/2024 04:05 PM EST GlobeNewswire Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/12/2024 04:30 PM EST GlobeNewswire Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
11/12/2024 04:01 PM EST GlobeNewswire Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
11/12/2024 08:30 AM EST GlobeNewswire Mustang Bio Receives Positive Listing Determination from Nasdaq
11/07/2024 08:30 AM EST GlobeNewswire Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
11/04/2024 07:00 AM EST GlobeNewswire Journey Medical Corporation Announces U.S. FDA Approval of Emrosi(TM) (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
10/25/2024 08:30 AM EDT GlobeNewswire Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
10/24/2024 02:10 PM EDT GlobeNewswire Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
Page

Additional News

As of January 4, 2025 • 10:00 AM ET

Date/Time Source News Release
12/16/2024 11:38 AM EST SeekingAlpha Checkpoint gets FDA approval for Unloxcyt for carcinoma
11/17/2024 04:40 AM EST US Earnings Reports Expected earnings - Fortress Biotech Inc.
11/14/2024 05:33 PM EST SeekingAlpha Fortress Biotech GAAP EPS of -$0.76 misses by $0.17, revenue of $14.62M
09/27/2024 05:00 PM EDT SeekingAlpha Fortress Biotech files to sell 6.19M shares of common stock for holders
09/20/2024 10:59 AM EDT SeekingAlpha Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering
09/02/2024 08:50 AM EDT Zacks Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock
09/01/2024 05:40 AM EDT US Earnings Reports Expected earnings - Fortress Biotech Inc.
08/13/2024 05:48 PM EDT SeekingAlpha Fortress Biotech GAAP EPS of -$0.73 beats by $0.49, revenue of $14.9M beats by $0.13M
08/13/2024 05:15 PM EDT Zacks Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates
08/08/2024 09:20 AM EDT Zacks Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates
Page